oxcarbazepine has been researched along with Epilepsy, Absence in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Byun, JI; Cho, YW; Kang, KW; Kim, D; Kim, DW; Kim, JM; Kim, KT; Lee, ST; No, YJ; Seo, JG; Yang, KI | 1 |
Clarke, AL; Morris, MJ; O'Brien, TJ; Petrou, S; Reid, CA; Zheng, T | 1 |
Degroote, E; Ghariani, S; Rostomashvili, N; van Rijckevorsel, K; Vrielynck, P | 1 |
Abou-Khalil, B; Bautista, J; Bazil, C; Bergen, D; Beydoun, A; Bourgeois, B; Browne, T; Faught, RE; Fischer, JH; French, JA; Gidal, B; Glauser, TA; Harden, CL; Hirtz, D; Kanner, AM; Marks, WJ; Montouris, GD; Nespeca, M; Sachdeo, RC; Schachter, SC; Stern, J; Theodore, WH; Turk, WR; Wilner, A | 1 |
Baldy-Moulinier, M; Crespel, A; Gelisse, P; Genton, P; Kuate, C; Pesenti, A | 1 |
Aneja, S; Jain, P; Sharma, S | 1 |
Johannessen, SI; Nakken, KO | 1 |
2 review(s) available for oxcarbazepine and Epilepsy, Absence
Article | Year |
---|---|
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
Topics: Acetates; Adolescent; Adult; Age Factors; Amines; Antipsychotic Agents; Carbamazepine; Child; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drug Approval; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Generalized; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Tiagabine; Topiramate; Triazines; United States; United States Food and Drug Administration; Zonisamide | 2004 |
[Seizure exacerbation caused by antiepileptic drugs].
Topics: Anticonvulsants; Carbamazepine; Disease Progression; Epilepsies, Myoclonic; Epilepsy; Epilepsy, Absence; Humans; Polypharmacy; Risk Factors | 2008 |
5 other study(ies) available for oxcarbazepine and Epilepsy, Absence
Article | Year |
---|---|
Treatment of epilepsy in adults: Expert opinion in South Korea.
Topics: Adult; Aged; Anticonvulsants; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Generalized; Expert Testimony; Female; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Republic of Korea; Surveys and Questionnaires; Treatment Outcome; Valproic Acid; Young Adult | 2020 |
Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Electroencephalography; Epilepsy, Absence; Female; Oxcarbazepine; Rats; Receptors, GABA-A | 2009 |
Perioral myoclonia with absences and myoclonic status aggravated by oxcarbazepine.
Topics: Anticonvulsants; Brain; Carbamazepine; Child; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, Absence; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Oxcarbazepine; Piracetam | 2011 |
Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Diagnostic Errors; Drug Administration Schedule; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Generalized; Female; Humans; Male; Myoclonic Epilepsy, Juvenile; Oxcarbazepine | 2004 |
Teaching video neuroimages: perioral myoclonia with absences in a 12-year-old boy.
Topics: Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, Absence; Humans; Male; Video Recording | 2013 |